Recent sequencing efforts have unveiled the widespread presence of cells—often organised as clones—carrying canonical cancer mutations within our tissues such as TP53, FAT1 and NOTCH1. Remarkably, many of these clones are functionally and phenotypically normal, with some even undergoing positive selection [3–7]. This evidence concerns the gene TP53 and cancer.